Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1948 1
1949 1
1950 1
1951 2
1954 4
1955 1
1956 3
1957 3
1958 1
1960 2
1961 4
1962 3
1963 1
1965 9
1966 3
1967 3
1968 2
1969 1
1970 2
1971 10
1972 1
1973 4
1974 7
1975 5
1976 9
1977 4
1978 1
1979 2
1980 4
1981 6
1982 4
1983 7
1984 6
1985 3
1986 6
1987 11
1988 12
1989 9
1990 8
1991 18
1992 28
1993 16
1994 13
1995 15
1996 19
1997 20
1998 30
1999 19
2000 25
2001 26
2002 31
2003 36
2004 29
2005 49
2006 45
2007 54
2008 82
2009 82
2010 101
2011 91
2012 113
2013 99
2014 123
2015 129
2016 129
2017 138
2018 149
2019 165
2020 211
2021 239
2022 268
2023 217
2024 109

Text availability

Article attribute

Article type

Publication date

Search Results

2,730 results

Results by year

Filters applied: . Clear all
Page 1
Cardiorenal benefits of finerenone: protecting kidney and heart.
González-Juanatey JR, Górriz JL, Ortiz A, Valle A, Soler MJ, Facila L. González-Juanatey JR, et al. Among authors: ortiz a. Ann Med. 2023 Dec;55(1):502-513. doi: 10.1080/07853890.2023.2171110. Ann Med. 2023. PMID: 36719097 Free PMC article. Review.
Regulated cell death pathways in kidney disease.
Sanz AB, Sanchez-Niño MD, Ramos AM, Ortiz A. Sanz AB, et al. Among authors: ortiz a. Nat Rev Nephrol. 2023 May;19(5):281-299. doi: 10.1038/s41581-023-00694-0. Epub 2023 Mar 23. Nat Rev Nephrol. 2023. PMID: 36959481 Free PMC article. Review.
Antifibrotic Agents for the Management of CKD: A Review.
Ruiz-Ortega M, Lamas S, Ortiz A. Ruiz-Ortega M, et al. Among authors: ortiz a. Am J Kidney Dis. 2022 Aug;80(2):251-263. doi: 10.1053/j.ajkd.2021.11.010. Epub 2022 Jan 6. Am J Kidney Dis. 2022. PMID: 34999158 Review.
Targeting inflammation to treat diabetic kidney disease: the road to 2030.
Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernández C, Marchant V, Donate-Correa J, Navarro-González JF, Ortiz A, Ruiz-Ortega M. Rayego-Mateos S, et al. Among authors: ortiz a. Kidney Int. 2023 Feb;103(2):282-296. doi: 10.1016/j.kint.2022.10.030. Epub 2022 Dec 5. Kidney Int. 2023. PMID: 36470394 Review.
Novel Treatments Paradigms: Membranous Nephropathy.
Rojas-Rivera JE, Ortiz A, Fervenza FC. Rojas-Rivera JE, et al. Among authors: ortiz a. Kidney Int Rep. 2023 Jan 2;8(3):419-431. doi: 10.1016/j.ekir.2022.12.011. eCollection 2023 Mar. Kidney Int Rep. 2023. PMID: 36938069 Free PMC article. Review.
Prevention of cardiorenal damage: importance of albuminuria.
Ruilope LM, Ortiz A, Lucia A, Miranda B, Alvarez-Llamas G, Barderas MG, Volpe M, Ruiz-Hurtado G, Pitt B. Ruilope LM, et al. Among authors: ortiz a. Eur Heart J. 2023 Apr 1;44(13):1112-1123. doi: 10.1093/eurheartj/ehac683. Eur Heart J. 2023. PMID: 36477861 Review.
Tirzepatide and prevention of chronic kidney disease.
Bosch C, Carriazo S, Soler MJ, Ortiz A, Fernandez-Fernandez B. Bosch C, et al. Among authors: ortiz a. Clin Kidney J. 2022 Dec 23;16(5):797-808. doi: 10.1093/ckj/sfac274. eCollection 2023 May. Clin Kidney J. 2022. PMID: 37151412 Free PMC article. Review.
Molecular Mechanisms of Kidney Injury and Repair.
Rayego-Mateos S, Marquez-Expósito L, Rodrigues-Diez R, Sanz AB, Guiteras R, Doladé N, Rubio-Soto I, Manonelles A, Codina S, Ortiz A, Cruzado JM, Ruiz-Ortega M, Sola A. Rayego-Mateos S, et al. Among authors: ortiz a. Int J Mol Sci. 2022 Jan 28;23(3):1542. doi: 10.3390/ijms23031542. Int J Mol Sci. 2022. PMID: 35163470 Free PMC article. Review.
2,730 results